Pramipexole dihydrochloride 1 MG Oral Tablet

1 INDICATIONS AND USAGE Pramipexole dihydrochloride tablets are non-ergot dopamine agonist indicated for the treatment of: • Parkinson’s disease (PD) ( 1.1 ) 1.1 Parkinson's Disease Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease.

Sandoz Inc

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] dyspnoea` `[5] diarrhoea` `[6] off label use` `[7] pain` `[8] headache` `[9] dizziness` `[10] vomiting`

4 years ago

ROUND WHITE SZ 17 6

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Pramipexole dihydrochloride tablets are available as follows: 0.125 mg, white to off-white, uncoated, round shaped tablets, one side debossed with ‘SZ’ and other side debossed with ‘173’. NDC 0781-5248-92, bottle of 90 tablets NDC 0781-5248-13, in unit-of-use pack of 100 tablets (10 blister cards, each containing 10 tablets) 0.25 mg, white to off-white, uncoated, oval shaped tablets, one side debossed with ‘S’ & ‘Z’ on either side of scoreline and other side debossed with ‘17’& ‘4’ on either side of scoreline. NDC 0781-5249-31, bottle of 30 tablets NDC 0781-5249-60, bottle of 60 tablets NDC 0781-5249-92, bottle of 90 tablets NDC 0781-5249-13, in unit-of-use pack of 100 tablets (10 blister cards, each containing 10 tablets) 0.5 mg, white to off-white, uncoated, oval shaped tablets, one side debossed with ‘S’ & ‘Z’ on either side of scoreline and other side debossed with ‘17’ & ‘5’ on either side of scoreline. NDC 0781-5250-31, bottle of 30 tablets NDC 0781-5250-60, bottle of 60 tablets NDC 0781-5250-92, bottle of 90 tablets NDC 0781-5250-13, in unit-of-use pack of 100 tablets (10 blister cards, each containing 10 tablets) 0.75 mg, white to off-white, uncoated, oval shaped tablets, one side debossed with ‘SZ’ and other side debossed with ‘178’. NDC 0781-5281-31, bottle of 30 tablets NDC 0781-5281-60, bottle of 60 tablets NDC 0781-5281-92, bottle of 90 tablets NDC 0781-5281-13, in unit-of-use pack of 100 tablets (10 blister card, containing 10 tablets) 1 mg, white to off-white, uncoated, round shaped tablets, one side debossed with ‘S’ & ‘Z’ on either side of scoreline and other side side debossed with ‘17’ & ‘6’ on either side of scoreline. NDC 0781-5251-31, bottle of 30 tablets NDC 0781-5251-60, bottle of 60 tablets NDC 0781-5251-92, bottle of 90 tablets NDC 0781-5251-13, in unit-of-use pack of 100 tablets (10 blister cards, each containing 10 tablets) 1.5 mg, white of off-white, uncoated, round shaped tablets, one side debossed with ‘S’ & ‘Z’ on either side of scoreline and other side debossed with ‘17’ & ‘7’ on either side of scoreline. NDC 0781-5252-31, bottle of 30 tablets NDC 0781-5252-60, bottle of 60 tablets NDC 0781-5252-92, bottle of 90 tablets NDC 0781-5252-13, in unit-of-use pack of 100 tablets (10 blister cards, each containing 10 tablets) 16.2 Storage and Handling Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Protect from light. Store in a safe place out of the reach of children.

More pills like ROUND SZ 17 6

Related Pills

Pramipexole dihydrochloride 0.75 MG Oral Tablet

Sandoz Inc

Pramipexole dihydrochloride 1.5 MG Oral Tablet

Sandoz Inc

Pramipexole dihydrochloride 0.5 MG Oral Tablet

Sandoz Inc

Pramipexole dihydrochloride 0.25 MG Oral Tablet

Sandoz Inc

pramipexole dihydrochloride tablet

sandoz inc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site